China SXT Pharmaceuticals regains compliance with Nasdaq's minimum bid price deficiency
Source: SeekingAlpha
2025-03-17 08:43:32 ET
More on China SXT Pharmaceuticals
Read the full article on Seeking Alpha
For further details see:
China SXT Pharmaceuticals regains compliance with Nasdaq’s minimum bid price deficiency
China SXT Pharmaceuticals Inc.
NASDAQ: SXTC
SXTC Trading
4.02% G/L:
$2.15 Last:
14,199 Volume:
$2.08 Open:
SXTC Latest News
January 15, 2026 09:00:00 am
CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC INITIATIVE TO APPLY AI TECHNOLOGY ACROSS THE TCM SUPPLY CHAIN
January 13, 2026 05:00:00 pm
Univest Securities, LLC Announces Closing of $10 Million Registered Direct Offering for its Client China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC)
January 09, 2026 02:50:00 pm
China SXT Pharmaceuticals Inc. Announces $10 Million Registered Direct Offering
